Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Jim Cramer on Lam Research Corporation (LRCX): ‘I Think Lam Is Dramatically Oversold’

We recently compiled a list of the Jim Cramer’s Top 10 Stock Picks You Can’t Ignore. In this article, we are going to take a look at where Lam Research Corporation (NASDAQ:LRCX) stands against Jim Cramer’s top stock picks.

In a recent episode of Mad Money, Jim Cramer discussed the current divide between tech stocks and other sectors, highlighting their tendency to move in opposite directions. For example, on a day when the Dow Jones Industrial Average increased by 228 points and the S&P 500 went up by 0.13%, the NASDAQ, which is heavily influenced by tech stocks, dropped by 0.52%. Cramer thinks it’s because there isn’t enough new money flowing into the market.

“How did we get to this bizarre dichotomy between tech stocks and pretty much everything else, where the two groups now almost always seem to move in opposite directions? Take today: the Dow Jones Industrial Average gained 228 points, the S&P advanced 0.13%, but the NASDAQ—with all that tech in it—dropped a bomb. Yes, it fell 0.52%. How could there be such a schism?”

As a result, large institutions need to move their investments between sectors since they can’t invest in both at once. This shift is due to market mechanics rather than fundamental news. When stocks are already doing well, it’s difficult to attract new investment, especially when safer options provide attractive returns. Therefore, either tech stocks or other sectors will perform well, but not both simultaneously.

“It’s because there’s not enough money coming in from the sidelines, so these big institutions have to swap out of one group if they want to buy stock in another. Yet this action has nothing to do with fundamentals; it’s not about the news, it’s about pure market mechanics. When stocks are already red hot, it’s hard to attract new capital from the sidelines, especially when you can get a cozy 4% return for doing nothing. So, either tech wins or everything else wins, but there’s not enough cash for both of them to win at the same time.”

Market Shake-Up: Clear Winners and Losers Amid Fed’s Critical Rate Decision

Cramer notes that this situation results in distinct winners and losers, rather than a range of performance on a positive day. This is occurring amid uncertainty about whether the Federal Reserve will reduce interest rates by 25 or 50 basis points in their upcoming meeting. Cramer also notes that, despite his usual reluctance to speculate on the Fed’s decisions, recent market movements have been swayed by expectations of rate cuts. For example, when The Wall Street Journal indicated the Fed might choose a 50 basis point reduction, there was a notable shift towards cyclical stocks, particularly those related to housing. This shift, along with other positive news, contributed to the market’s best week of the year.

“What happens? We get winners and losers—not big winners and smaller winners, as you would normally expect on an up day like today. This is all against the backdrop of the big question: will the Fed cut rates by 25 basis points or 50 when it meets on Wednesday?

Now, you know me, I try to refrain from this parlor game of guessing the Fed’s next move based on the strength of the economy. Last week, when *The Wall Street Journal* indicated the Fed may actually be leaning toward 50 basis points, we saw this great migration into cyclicals, especially anything related to housing. Of course, last week, there was just enough good news to propel the entire market, which is why it was the best week of the year.

This leads me to this newfound great divide between tech and non-tech, because that’s how this market seems to be trading. It’s a big reason why I’m out here in Silicon Valley this week. Today, we saw a market that doesn’t believe in AI, or tech in general for that matter. It’s a market that believes a 50-basis-point rate cut will shift money from semiconductors to housing and anything housing-related, and people want to get ahead of that.”

Jim Cramer’s Definition of ABT: “Anything But Tech”

Jim Cramer noted that Monday’s market saw a wide range of winners. Healthcare stocks, retailers, and consumer packaged goods companies all did well, and even oil stocks, which have been lagging, are rebounding. This is unusual because typically when cyclical stocks rise, sectors like healthcare and consumer products would drop. Cramer explains this trend as part of a broader market shift he calls “ABT,” or “anything but tech.” Essentially, today’s market is focusing on sectors outside of technology.

“Today, the winners broadened out. The healthcare stocks got jiggy, retailers worked, and consumer packaged goods companies outperformed. Even the much-maligned oils are rallying. It’s crazy—healthcare and consumer products should be selling off when cyclicals rally, but that’s not what’s happening because it’s *ABT*. No, I’m not talking about the symbol for Abbott Labs. ABT means “anything but tech,” and that’s what today’s market was about.

The implications are pretty stark, folks. Market commentators call this a rotation, but that understates what’s really happening here because the move is so vicious and devoid of realism. The market’s action is dictating what we do. For example, we know that the principal beneficiaries of rate cuts are the housing stocks, which rallied again today. This is the second day these stocks jumped as rates continue to plummet. But today, day two, was zero-sum.”

Tech stocks also experienced notable gains because of key events. For example, Larry Ellison from Oracle reported strong earnings and emphasized the need for many additional data centers.

Our Methodology

This article summarizes Jim Cramer’s latest Mad Money episode, where he discussed various stocks. We have selected the ten most notable companies he mentioned and ranked them based on their ownership levels by hedge funds, from the least owned to the most owned.

At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

A technician operating an automated semiconductor processing machine with laser accuracy.

Lam Research Corporation (NASDAQ:LRCX)

Number of Hedge Fund Investors: 84

Jim Cramer believes that Lam Research Corporation (NASDAQ:LRCX) is significantly undervalued and could potentially rebound strongly, with the possibility of a 200-point increase despite a potential 50-point drop. He agreed with a viewer’s view on Lam Research Corporation (NASDAQ:LRCX), emphasizing his extensive experience with Lam Research Corporation (NASDAQ:LRCX) compared to current traders. Cramer advised against trying to follow the recent tech sell-off, as it often leads to wasted effort and financial losses.

“I think Lam is dramatically oversold. I think it could be a coiled spring. Maybe it has 50 points down, but I think it could have 200 points up. I agree with you, and I’ve known the company for a very long time, certainly more than the traders who are dumping it right now. So anyway, don’t try to chase this move out of tech, please. I’ve seen this kind of thing before, it’s just not worth your effort. It will only result in you churning your dollars and losing money.”

Lam Research Corporation (NASDAQ:LRCX) presents a strong case for growth, thanks to its solid performance in the semiconductor sector and multiple growth opportunities. Lam Research Corporation (NASDAQ:LRCX) has consistently exceeded market expectations, as shown by its Q4 fiscal 2024 earnings report, where it posted $3.87 billion in revenue and an EPS of $7.78, both higher than predicted.

Key factors driving this growth include the increasing demand for AI-powered chips, high-bandwidth memory (HBM), 3D DRAM, and advanced packaging technologies. Additionally, rising demand for NAND memory, driven by technological advancements, plays a significant role, with Lam Research Corporation (NASDAQ:LRCX) leading in NAND etching technology.

Lam Research Corporation (NASDAQ:LRCX)’s strategic focus on research and development (R&D) and expanded production capabilities position it well to take advantage of these industry trends. Further boosting confidence, hedge funds, institutional investors, and positive analyst ratings reflect a strong belief in Lam Research Corporation (NASDAQ:LRCX)’s long-term growth potential. With the AI and memory markets on the rise, Lam Research Corporation (NASDAQ:LRCX) is well-positioned for continued earnings growth in the future.

Artisan Select Equity Fund stated the following regarding Lam Research Corporation (NASDAQ:LRCX) in its Q2 2024 investor letter:

“The top contributors to performance for the quarter were Alphabet, Lam Research Corporation (NASDAQ:LRCX) and Elevance. Lam Research shares rose 10% during the quarter and are up 67% over the past year, primarily due to optimism around the pending investment cycle in semiconductor capital expenditures. Lam is one of the largest equipment manufacturers used to make semiconductor chips.

This equipment, commonly referred to as WFE (wafer fabrication equipment), is expected to experience significant growth due to a combination of a cyclical rebound in memory chips and growing demand for new AI-related chips. Lam’s product portfolio is particularly well positioned to benefit from both trends and should grow even faster than the overall market. Its shares now trade at ~30X prior peak earnings, which suggests this dynamic is well understood by the market and is mostly priced in.”

Overall LRCX ranks 5th on our list of Jim Cramer’s top stock picks. While we acknowledge the potential of LRCX as an investment, our conviction lies in the belief that under the radar AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than LRCX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley and Jim Cramer Says NVIDIA ‘Has Become A Wasteland’.

Disclosure: None. This article is originally published at Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…